Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
Abstract Background When use of a single antiseizure medication (ASM) fails to induce seizure remission, add-on therapy is justified. Perampanel (PER) is approved in Europe as adjunctive therapy for focal, focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures. Aim of the stu...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2021-10-01
|
| Serier: | BMC Neurology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12883-021-02450-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
